Deficiency of the scavenger receptor class B type I (SR-BI) protein in mice is associated with significantly increased plasma HDL-C levels, paradoxically accelerated atherosclerosis despite increased HDL-C levels, and infertility in female mice. We were the first to report associations with these same phenotypes in humans with certain SR-BI gene (SCARB1) single nucleotide polymorphisms (SNPs). Among these SNPs, rs10846744, a noncoding SNP (G>C) within intron 1 located at a regulatory site, was significantly associated with increased subclinical atherosclerosis (SCA) and increased odds for cardiovascular disease (CVD) in Multi-Ethnic Study of Atherosclerosis (MESA) participants. Importantly, inclusion of traditional CVD risk factors in a multivariate regression model did not attenuate the association of rs10846744 with CVD, strongly suggesting that other pathway(s), including an inflammatory one, likely drive this important clinical association. We used RNA-Seq to examine transcriptional differences in gene expression between lymphocytes isolated from hyperalphalipoproteinemic (HALP) carriers homozygous for the SCARB1 rs10846744 reference (GG) allele with carriers homozygous for the risk (CC) allele. We identified lymphocyte activation gene-3 (LAG-3, on chromosome 12p13.31), a gene that encodes LAG-3 protein, and which binds major histocompatibility complex II to suppress expansion of T effector cells, as a strong candidate in the rs10846744 CVD risk pathway. The hypothesis to be tested in this application is that LAG-3 protein deficiency, via a pro-inflammatory effect, exerts a major influence in the association of the SCARB1 rs10846744 SNP with SCA and CVD. We will use three specific aims to test the hypothesis: (1) To determine the mechanism of LAG-3 protein in regulating the pro-inflammatory state of SCARB1 rs10846744 risk (CC) cells, (2) To determine the effect of LAG-3 protein deficiency in a murine model of atherosclerosis, and (3) To examine LAG-3 protein as an independent predictor of SCA and CVD risk in MESA. The long term objective of this project is to unravel the novel intersection of the SCARB1 rs10846744 variant and the immune checkpoint inhibitor LAG-3 protein in CVD risk.

Public Health Relevance

Heart disease remains a leading cause of death in the United States and throughout the world. We are now better appreciating the role of genetics as a cause for heart disease. Our research work will examine the intersection of genetics, cholesterol, and inflammation in the causes of heart disease. The results of our work will provide customized approaches in the medical treatment of people with certain genetic cholesterol problems and heart disease.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL131862-02
Application #
9337489
Study Section
Atherosclerosis and Inflammation of the Cardiovascular System Study Section (AICS)
Program Officer
Iturriaga, Erin
Project Start
2016-09-01
Project End
2020-05-31
Budget Start
2017-06-01
Budget End
2018-05-31
Support Year
2
Fiscal Year
2017
Total Cost
$732,924
Indirect Cost
$180,283
Name
University of Connecticut
Department
Biology
Type
Schools of Medicine
DUNS #
022254226
City
Farmington
State
CT
Country
United States
Zip Code
06030